Latest filing published 02 Apr 2026 for ImmunityBio, Inc., €21.6M.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Filings by Patrick Soon-Shiong span 5 companies, the busiest being Jakks Pacific Inc, Tribune Publishing Co and ImmunityBio, Inc. Between 28 July 2015 and 31 March 2026, the trades on record add up to 90 filings.
The open-market side counts 32 purchases for €111.9M alongside 34 sales for €13.1M. The totals exclude 2 filings filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 3 share grants and 5 option exercises.
A typical purchase (the median) is worth €313k. Clusters matter here: 20 out of 31 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
The newest entry dates from 2 April 2026: a transaction of €21.6M, in ImmunityBio, Inc. The last insider purchase was made public on 30 August 2023, 1,150 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations